Polyclonal antibody Candistat GAlternative Names: Candistat G
Latest Information Update: 02 Dec 1998
At a glance
- Originator GalaGen
- Class Antifungals; Polyclonal antibodies
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 02 Dec 1998 Discontinued-II for Candidiasis in Sweden (PO)
- 28 Aug 1997 New profile
- 28 Aug 1997 Phase-II clinical trials for Candidiasis in Sweden (PO)